-
Signature
-
/s/ Kristen Williams, Attorney-in-Fact
-
Issuer symbol
-
PCRX
-
Transactions as of
-
12 Jun 2024
-
Net transactions value
-
-$24,974
-
Form type
-
4
-
Filing time
-
13 Jun 2024, 18:13:00 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PCRX |
Common Stock |
Award |
$0 |
+5,230 |
+62% |
$0.000000 |
13,604 |
12 Jun 2024 |
Direct |
F1 |
| transaction |
PCRX |
Common Stock |
Sale |
$24,974 |
-880 |
-6.5% |
$28.38 |
12,724 |
13 Jun 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PCRX |
Stock Option (Right to Buy) |
Award |
$0 |
+12,179 |
|
$0.000000 |
12,179 |
12 Jun 2024 |
Common Stock |
12,179 |
$28.68 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: